Vor Biopharma Inc. Stock Analysis & AI Score
Vor Biopharma Inc. (VOR) has an ST Score of 59.9 (B-), driven by its Financial Strength (A+) and held back by its Momentum (C). Analysts rate it Buy with a $29.00 price target (+57.3% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Vor Biopharma Inc. (VOR) has an ST Score of 59.9 (B-), driven by its Financial Strength (A+) and held back by its Momentum (C). Analysts rate it Buy with a $29.00 price target (+57.3% upside).
- Strongest
- Financial StrengthA+
- Weakest
- MomentumC
All factor grades
- Financial StrengthA+
- ForecastB+
- GrowthB
- ValuationB-
- ProfitabilityB-
- MomentumC
- Piotroski3/9
Contact
VOR stock: frequently asked questions
What is VOR's ST Score?
Vor Biopharma Inc. (VOR) has an ST Score of 59.9 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is VOR a buy, hold, or sell?
Analysts rate VOR a Buy, with a price target of $29.00 (+57.3% vs the current price). Our ST Score grades it B- (59.9/100). The ST Score is a data-driven signal, not a recommendation.
What are VOR's factor grades?
Valuation B-, Profitability B-, Financial Strength A+, Momentum C, Growth B, Forecast B+.
What is VOR's valuation grade?
Vor Biopharma Inc. (VOR) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is VOR's growth grade?
Vor Biopharma Inc. (VOR) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is VOR's profitability grade?
Vor Biopharma Inc. (VOR) earns a profitability grade of B-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is VOR's financial strength grade?
Vor Biopharma Inc. (VOR) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for VOR?
The average analyst price target for Vor Biopharma Inc. (VOR) is $29.00 from 13 analysts, which is +57.3% versus the recent price of $18.44.
What is VOR's Piotroski score?
Vor Biopharma Inc. (VOR) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.